CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Explore how to use credit card rewards for gift purchases. Make your shopping budget stretch further during the holidays.
13,959 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Chips led a broad market dip at midday as investors weighed AI headlines against inflation risks and possible rate hi...
SpaceX's planned IPO has drawn record demand, but market watchers warn buyers to scrutinize the order book for true d...
With the Fed set to act this month, a dirt-cheap stock looks attractive amid crosscurrents in the market. Here’s why ...
SpaceX gears up for the largest IPO in history on Nasdaq, while a 1:1 tokenized SpaceX equity trades on Solana. Backp...
Lemonade is doubling down on artificial intelligence to reshape insurance. This piece breaks down what lemonade betti...
U.S. stocks and futures react to a fresh batch of analyst calls on Dynatrace, Emerson Electric, Exxon Mobil and more....
The Northeast is seeing a rapid rise in million-dollar starter homes, reshaping the landscape for millennial parents ...
SpaceX has landed a historic IPO. This article lays out a 180-day plan for investors, with key dates, valuations, and...
A AI-powered crypto project is stirring excitement. This deep dive explains how Bittensor could crack the top 10 by m...
As crypto and precious metals slide, investors eye Robert Kiyosaki’s stance. He emphasizes context over price, signal...
CBRE reports shrinking data-center vacancy in major markets, signaling a tight supply outlook. Nebius could see meani...